These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6707878)

  • 41. Hygroscopic stability and dissolution properties of spray-dried solid dispersions of furosemide with Eudragit.
    Otsuka M; Onoe M; Matsuda Y
    J Pharm Sci; 1993 Jan; 82(1):32-8. PubMed ID: 8429488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved dissolution of an insoluble drug using a 4-fluid nozzle spray-drying technique.
    Chen R; Tagawa M; Hoshi N; Ogura T; Okamoto H; Danjo K
    Chem Pharm Bull (Tokyo); 2004 Sep; 52(9):1066-70. PubMed ID: 15340191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine.
    Najafabadi AR; Gilani K; Barghi M; Rafiee-Tehrani M
    Int J Pharm; 2004 Nov; 285(1-2):97-108. PubMed ID: 15488683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pioglitazone solid dispersion system prepared by spray drying method: in vitro and in vivo evaluation.
    Pokharkar V; Kutwal M; Mandpe L
    PDA J Pharm Sci Technol; 2013; 67(1):23-34. PubMed ID: 23385561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physical and structural comparison of oxyphenbutazone monohydrate and anhydrate.
    Stoltz M; Caira MR; Lotter AP; van der Watt JG
    J Pharm Sci; 1989 Sep; 78(9):758-63. PubMed ID: 2585271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of polymorphs and solvates of 3-amino-1-(m-trifluoromethylphenyl)-6-methyl-1H-pyridazin-4-one.
    Chauvet A; Masse J; Ribet JP; Bigg D; Autin JM; Maurel JL; Patoiseau JF; Jaud J
    J Pharm Sci; 1992 Aug; 81(8):836-41. PubMed ID: 1357154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural relationships, thermal properties, and physicochemical characterization of anhydrous and solvated crystalline forms of tetroxoprim.
    Caira MR; Bettinetti G; Sorrenti M
    J Pharm Sci; 2002 Feb; 91(2):467-81. PubMed ID: 11835206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of recrystallization of amorphous trehalose through hot-humidity stage X-ray powder diffraction.
    Jójárt-Laczkovich O; Katona G; Aigner Z; Szabó-Révész P
    Eur J Pharm Sci; 2016 Dec; 95():145-151. PubMed ID: 27496047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of two polymorphs of lornoxicam.
    Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S
    J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physical characterization of two oxyphenbutazone pseudopolymorphs.
    Stoltz M; Lötter AP; Van der Watt JG
    J Pharm Sci; 1988 Dec; 77(12):1047-9. PubMed ID: 3244109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Solubility and crystal nucleation in organic solvents of two polymorphs of curcumin.
    Liu J; Svärd M; Hippen P; Rasmuson ÅC
    J Pharm Sci; 2015 Jul; 104(7):2183-9. PubMed ID: 25950658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation and physicochemical characterization of spray-dried and jet-milled microparticles containing bosentan hydrate for dry powder inhalation aerosols.
    Lee HJ; Kang JH; Lee HG; Kim DW; Rhee YS; Kim JY; Park ES; Park CW
    Drug Des Devel Ther; 2016; 10():4017-4030. PubMed ID: 28008226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form.
    Xiong X; Xu K; Li S; Tang P; Xiao Y; Li H
    Drug Dev Ind Pharm; 2017 Feb; 43(2):283-292. PubMed ID: 27648489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trehalose amorphization and recrystallization.
    Sussich F; Cesàro A
    Carbohydr Res; 2008 Oct; 343(15):2667-74. PubMed ID: 18768170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of the spontaneous polymorphic transition of pyrazinamide γ form at room temperature by co-spray drying with 1,3-dimethylurea.
    Baaklini G; Dupray V; Coquerel G
    Int J Pharm; 2015 Feb; 479(1):163-70. PubMed ID: 25556055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physical characterization and dissolution performance assessment of Etravirine solid dispersions prepared by spray drying process.
    Kommavarapu P; Maruthapillai A; Palanisamy K; Koya RT
    Pak J Pharm Sci; 2016 Nov; 29(6):2023-2031. PubMed ID: 28375119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior.
    Kimura K; Hirayama F; Uekama K
    J Pharm Sci; 1999 Apr; 88(4):385-91. PubMed ID: 10187747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.